Nipro Launches D2F™ Glass Vials Powered by Stevanato Group's EZ-fill® Technology

This high-quality ready-to-use (RTU) solution is designed to meet the rigorous standards and increasing requirements of the pharmaceutical industry.

D2F™ vials’ nest & tub design prevents glass-to-glass contact, reducing risks of breakage, cosmetic defects, and particle generation during transportation and handling.
D2F™ vials’ nest & tub design prevents glass-to-glass contact, reducing risks of breakage, cosmetic defects, and particle generation during transportation and handling.
Nipro PharmaPackaging

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Nipro PharmaPackaging, a global leader in glass tubing, glass primary packaging, and medical devices, is proud to announce the launch of its innovative D2F™ (Direct-to-Fill) glass vials.These vials, featuring Stevanato Group’s advanced EZ-fill® technology, offer a high-quality ready-to-use (RTU) solution designed to meet the rigorous standards and increasing requirements of the pharmaceutical industry.

Key Features of D2F™ Glass Vials

·     Direct-to-Fill Technology: D2F™ glass vials are washed, depyrogenated, packaged in nest & tub formats, and sterilized, providing a seamless RTU solution. Pharmaceutical companies can integrate these vials directly into their aseptic fill-finish processes.

·      Optimized for Fill-Finish Lines: Developed in collaboration with leading machine suppliers, D2F™ vials are compatible with a wide range of fill-finish lines, ensuring easy and quick integration, thus speeding up operations.

·      Increased Stability & Cost Efficiency: D2F™ vials’ nest & tub design prevents glass-to-glass contact, reducing risks of breakage, cosmetic defects, and particle generation during transportation and handling. This results in improved mechanical durability, lower downtime, and fewer rejections during final inspections, ultimately contributing to more stable and cost-efficient fill-finish operations.

“We are excited to introduce D2F™ glass vials, offering a reliable and efficient RTU packaging solution that addresses the evolving needs of the pharmaceutical industry,” said Stephan Arnold, CEO Nipro PharmaPackaging. “These vials exemplify our mission to delivering trust with premium primary pharma packaging solutions.

"The collaboration with Nipro represents another important milestone for Stevanato Group's EZ-fill® pre-sterilized platform," said Mauro Stocchi, Chief Business Officer at Stevanato Group. "Nipro's adoption of the EZ-fill® platform further validates Stevanato Group's technological leadership and strengthens our market position in secondary packaging for aseptic manufacturing. The EZ-fill® platform is an increasingly reliable, scalable, and cost-effective solution and industry-validated technology, and we believe it will become a widely recognized standard in the industry."

 

Fill out the form below to request more information about Nipro Launches D2F™ Glass Vials Powered by Stevanato Group's EZ-fill® Technology
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences